Strategies for Organ Regeneration Using Cell Therapy
-
By
-
L. Papamichail
-
L. J. W. van der Laan
-
A. A. Zadpoor
-
S. Lindstedt
-
M. J. Hoogduijn
-
February 25, 2026
-
Clinical Scorecard: Strategies for Organ Regeneration Using Cell Therapy
At a Glance
| Category | Detail |
|---|
| Condition | Degenerative diseases affecting organ function |
| Key Mechanisms | Cell replacement and stimulation of endogenous progenitor cells |
| Target Population | Patients with organ degeneration, particularly in the intestine, kidney, liver, lung, and heart |
| Care Setting | Clinical and research settings focusing on regenerative therapies |
Key Highlights
- Regenerative therapy aims to restore normal cell function or replace lost cells.
- Cell therapy for organ regeneration is still in early development compared to CAR T-cell therapy.
- Intestinal epithelium is a prime target for cell replacement due to its accessibility.
- Machine perfusion enhances the delivery and monitoring of regenerative cells.
- Successful engraftment of therapeutic cells can improve organ function.
Guideline-Based Recommendations
Diagnosis
- Identify degenerative organ conditions suitable for regenerative therapy.
Management
- Utilize cell replacement strategies and stimulation of resident progenitor cells.
Monitoring & Follow-up
- Assess engraftment efficiency and organ function post-therapy.
Risks
- Potential off-target cell accumulation and invasive delivery methods.
Patient & Prescribing Data
Patients with degenerative diseases of the intestine, kidney, liver, lung, and heart.
Use of autologous cells for transplantation in immunodeficient or syngeneic recipients.
Clinical Best Practices
- Employ advanced gene editing techniques for cell differentiation.
- Implement machine perfusion for improved cell delivery and organ preservation.
- Conduct thorough preclinical studies to evaluate cell therapy efficacy.
References
